Pacific Biosciences of California PACB Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashCurrent.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's restricted cash?
- Pacific Biosciences of California (PACB) reported restricted cash of $19K in Q1 2026.
- How has Pacific Biosciences of California's restricted cash changed year-over-year?
- Pacific Biosciences of California's restricted cash decreased by 97.2% year-over-year, from $690K to $19K.
- What is the long-term trend for Pacific Biosciences of California's restricted cash?
- Over 5 years (2020 to 2025), Pacific Biosciences of California's restricted cash has grown at a -52.6% compound annual growth rate (CAGR), from $836K to $20K.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.